Publisher
Springer International Publishing
Reference43 articles.
1. Hamouzadeh P, Sadrollahi A, Yousefvand M. The basis for calculating costs in health technologies assessment studies 2021.
2. Nordon C, Karcher H, Groenwold RH, Ankarfeldt MZ, Pichler F, Chevrou-Severac H, et al. The “efficacy-effectiveness gap”: historical background and current conceptualization. Value in Health 2016;19:75–81.
3. FDA. Framework for FDA’s real-world evidence program. Silver Spring, MD: US Department of Health and Human Services Food and Drug Administration 2018.
4. NICE. Real world evidence framework. London: National Institute for Health and Care Excellence (NICE), 2022. Available from: https://www.nice.org.uk/corporate/ecd9/resources/nice-realworld-evidence-framework-pdf-1124020816837.
5. Makady A, Ten Ham R, de Boer A, Hillege H, Klungel O, Goettsch W. Policies for use of real-world data in health technology assessment (HTA): a comparative study of six HTA agencies. Value in Health 2017;20:520–32.